Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Salix Finally Says Yes To Valeant In $158-Per-Share, $10.4 Billion Deal
Salix Finally Says Yes To Valeant In $158-Per-Share, $10.4 Billion Deal
Salix Finally Says Yes To Valeant In $158-Per-Share, $10.4 Billion Deal
Submitted by
admin
on February 23, 2015 - 5:50pm
Source:
Seeking Alpha
News Tags:
Salix
Valeant Pharmaceuticals
M&A
Headline:
Salix Finally Says Yes To Valeant In $158-Per-Share, $10.4 Billion Deal
Do Not Allow Advertisers to Use My Personal information
